Patient recruitment is one of the greatest challenges in conducting clinical trials. Although Europe and the United States share international regulatory standards such as ICH-GCP, the strategies and ...
Read moreComplete EU pivotal trial data highlights transformative potential of aXess in hemodialysis treatment
Read moreUna investigación con participación de la URV da el primer paso para desarrollar una herramienta que facilite la detección y el diagnóstico precoz de estas patologías
Read moreKits are ready-to-use solutions that support the introduction of defined or random DNA sequence modifications. Depending on the methodology, kits enable nucleotide substitutions, small insertions or d...
Read moreIn people living with obesity (BMI >30 kg/m²) and type 2 diabetes, the risk of developing MASLD and advanced liver fibrosis increases dramatically, often without symptoms.
Read moreFrom cancer research to neurodegenerative diseases, their partner, LifeSensors offers a wide range of technologies for ubiquitination, targeted protein degradation (TPD), PROTACs, molecular glues and ...
Read moreA public-private consortium led by the biotechnology company Nuage Therapeutics has initiated the development of an innovative therapy against the most frequent subtype of small cell lung cancer (SCLC...
Read moreOne of its main research lines focuses on exploring the therapeutic use of extracellular vesicles, small structures secreted by cells that can transport molecules with regulatory functions. In this ca...
Read moreResearchers from the Biomarkers of Cardiovascular Disease Progression group at the Institut de Recerca Sant Pau (IR Sant Pau) have identified a new mechanism by which complement C3, a key immune syste...
Read moreUn consorcio de investigadores europeos, liderado por el Cima Universidad de Navarra, describe el primer caso de porfiria por deficiencia de ALA deshidratasa en una niña
Read moreEl daño microvascular se produce cuando una parte del músculo cardiaco no recibe suficiente sangre, propiciando complicaciones a largo plazo como la insuficiencia cardiaca
Read moreEl reclutamiento de pacientes sigue siendo uno de los mayores retos en la ejecución de ensayos clínicos. No es extraño que más del 80% de los estudios se retrasen por dificultades para alcanzar lo...
Read more